ExploreWatchlistsPricing
  1. JP-listed companies
  2. TOWA PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Retained earnings

TOWA PHARMACEUTICAL CO.,LTD. (4553)

Market cap
¥220.2B
P/E ratio
11.9x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRetained earnings (Million JPY)YoY (%)
Mar 31, 2025150,502+11.94%
Mar 31, 2024134,452+10.90%
Mar 31, 2023121,232-0.74%
Mar 31, 2022122,131+12.43%
Mar 31, 2021108,629+11.79%
Mar 31, 202097,171+14.68%
Mar 31, 201984,734+16.37%
Mar 31, 201872,816+7.27%
Mar 31, 201767,879+6.36%
Mar 31, 201663,821+10.24%
Mar 31, 201557,893

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat